INTRODUCTION
T HE purpose of this report is twofold.
First, we shall describe a simply operated, accurate, and relatively sturdy machine, called a "flicker photometer," or "flicker meter," which may be used in a physician's office during routine physical examinations for the determination of the patient's visual threshold for the fusion frequency of flicker. Second, we shall indicate the potential usefulness of determining the response of the flicker fusion threshold (F.F.T.) to nitroglycerin in the diagnosis, prognosis, and therapy of subclinical cardiovascular disease. The response may in time prove to be practical for detecting a tendency toward coronary and hypertensive cardiovascular disease.
THE FLICKER FuSION THRESHOLD (F.F.T.)
The threshold of the fusion frequency of flicker refers to that frequency of successive flashes of light at Avhich the light stimulus appears to be continuous in intensity or free from flicker. For example, the ordinary Mazda electric lamp is usually supplied with a 60-cycle alternating current and the light stimulus from the lamp under these conditions does not flicker. However, if the 60 cycle alternating From the Department of Clinical Science, University of Illinois, and the Illinois Masonic Hospital, Chicago. Presented at the joint meeting of the Chicago Society of Internal Medicine and the Chicago Heart Association, December 19, 1949 December 19, . 1267 current is reduced to 50 cycles some persons will observe the lamp to flicker; and if reduced to 40 cycles, all "normal" persons will observe it to flicker. The fusion frequency of flicker is among the most fundamental of visual phenomena.1
The more intimate physiology of the phenomena has been studied in recent years by Crozier2
and Selig Hecht.3
The apparatus required to study the more intimate physiology of flicker fusion phenomena is quite bulky and relatively expensive.
In 1939 when we desired to ascertain if the F.F.T. might be used to measure objectively the subjective feeling of physical and mental tiredness in a patient, the machine we designed was heavy and bulky and required two persons to move it. In 1941, we constructed a small portable and inexpensive machine, which we used throughout the war in a study of the effect of hypoxia on bodily functions and the effect of certain drugs thereon.4 This machine was not sturdy, and considerable skill was required in its operation. The present machine has been developed during the past three years. Our experience with its use convinces us that it is sturdy and reliable and that almost any adult can learn to operate it w ithin ten minutes. The control dial, which controls the speed of the motor, is set at 3000 flashes per minute (50/sec.). The subject is then told that the frosted glass will be illuminated, that the light will be steady, and then it will flicker; and, when it flickers the subject should immediately say "now." Mhen the subject says "nows-," the light is turned off to prevent fatigue. The rate is recorded on paper, the "memory-(lial" set, and the control dial turned 200 or 300 above the setting of the memory dial. The light is turned on, the dial is turned slowly down, until the subject says "now." The light is turned off. Simonson, Enzer, and Blankstein7 have found that the F.F.T. is related to age although in some young subjects the F.F.T. is as low as in older persons. ltiddell8 has reported that lowered visual acuity decreases or impairs the threshold, though Enzer and his colleagues have stated that this statement cannot be generalizedl.
As far as we have been able to ascertain, Enzer, Simonson and Blankstein' are the only investigators who have studied the F.F.T. in patients wsith cardiovascular disease. They studied 21 patients with heart disease and in the retinal blood vessels in hypertensive disease, the anatomic changes are probably preceded by a physiologic hypertonus or spasm of the arterioles. Second, it was assumed that if this were true, then nitroglycerin and other vasodilators should abolish the hypertonus or spasm of the arterioles of the retina and by an active hyperemia improve the oxygen supply of the retina which in turn would improve the F.F.T. It was assumed in the third place that if the arterioles of the retina and visual pathways were normal that nitroglycerin wsould dilate the arterioles, cause passive congestion Illustrative results on 7 patients with slightly elevated blood pressure or with known coronary heart disease are shown in table 6 . In these patients it is to be noted that the second dose of nitroglycerin produced a "normal" response. However, in three patients with a very high blood pressure due to essential hypertension, * This group should be divided theoretically into those with and without generalized arteriosclerosis.
** All but one gave an "abnormal response"; that patient gave a normal response because he was on full doses of papaverine. In none of these patients was the heart decompensated.
It is worthy of note that the patient diagnosed as having a "(ardiac neurosis" had a normal electrocardiogram and F.F.T. The patients with thromboangiitis obliterans (Buerger's disease) gave an abnormal response.
the first dose of nitroglycerin may cause no change or only a slight increase or "abnormal" response and the second dose may cause a greater increase or "abnormal" response (table  6 ). This would indicate that the vasospastic tendency is more "fixed" in some patients than in others.
Possible Value of the Test in the Management of Diseases Due to or Complicated with Vasospasm. We have been maintaining a number of patients on papaverine. By using either nitroglycerin sublingually or papaverine (50 mg.) intravenously as the dilator, we have been able to ascertain whether the patient was receiving sufficient papaverine to obtain complete abolition of the vasospasm.
Although we have had no patients of our own on potassium thiocyanate, the test, using the results obtained must be cautiously interpreted. This is particularly true of the nitroglycerin-flicker test we have proposed in this paper. 1  2130  2250  2250  2250  +120  2250  2160  2100  2040  -210  2  2040  2100  2160  2160  +120  2160  2040  2100  2040  -120  3  1920  1950  1980  2070  +150  2070  1920  1920  1920  -150  4  2100  2300  2300  2400  +300  2400  2340  2280  2220  -180  5  2200  2300  2400  2400  +200  2400  2350  2300  1950  -450  6  2800  2500  2500  2500  +100   2500  2400  2350  2300  -200  7  2400  2460  2520  2580  +180  2580  2400  2400 glycerin might be due to a reduction of blood pressure rather than to the reduction of a vasomotor hypertonus or spasm. However, this suggestion is not tenable because the F.F.T. may improve after nitroglycerin in some patients with a normal blood pressure. SUMMARY 1. A sturdy and reliable flicker photometer or flicker meter which may be used in office practice has been designed. A method for using the apparatus for the determination of the threshold of the fusion frequency of flicker (F.F.T.) has been described.
2. The F.F.T. is lower than normal or impaired in patients with a definite hypertension or anemia and improves when these conditions respond to therapeutic control.
3. A nitroglycerin-flicker test has been devised. The test involves the determination of the F.F.T. before and at 2 minute intervals after placing nitroglycerin (0.4 mg.) under the tongue. In "normal" subjects nitroglycerin impaired the F.F.T. In 99 per cent of 216 patients with hypertension or coronary arterial disease, nitroglycerin improved the F.F.T.
4. In view of the fact that it is knowvn that arteriospastic retinitis occurs in advanced cases of hypertension and that anoxia of the visual mechanism impairs the F.F.T., the improvement of the F.F.T. after nitroglycerin is interpreted as being due to the relief of vasospasm and a consequent active hyperemia. The impairment in the normal subject after nitroglycerin is interpreted as being due to vasodilation and a consequent passive hyperemia of the visual mechanism.
5. Some evidence is presented which suggests that the nitroglycerin-flicker test may prove to be a valuable diagnostic aid (a) for the presence of angina pectoris and coronary occlusion where the evidence is equivocal, (b) for the detection and management of persons who may later develop hypertension and coronary arterial disease, and (c) for ascertaining whether a certain dose of a vasodilator drug is actually entirely counteracting a vasospastic condition in a patient. These are potentialities Which we believe merit much study.
